Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.7526
-0.0814 ( -9.76% ) 497.6K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.7526
Previous close
$0.8340
Volume
497.6K
Market cap
$128.82M
Day range
$0.7520 - $0.8720
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Feb 28, 2024 |
| 3 | Insider transactions | 1 | Feb 23, 2024 |
| 4 | Insider transactions | 1 | Feb 22, 2024 |
| 4 | Insider transactions | 1 | Feb 20, 2024 |
| 8-k | 8K-related | 14 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 3/a | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 15, 2024 |